These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 1374587)

  • 1. Persistent complement activation on tumor cells in breast cancer.
    Niculescu F; Rus HG; Retegan M; Vlaicu R
    Am J Pathol; 1992 May; 140(5):1039-43. PubMed ID: 1374587
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Immunohistochemical study of complement S protein (Vitronectin) in normal and diseased human kidneys: relationship to neoantigens of the C5b-9 terminal complex.
    Bariety J; Hinglais N; Bhakdi S; Mandet C; Rouchon M; Kazatchkine MD
    Clin Exp Immunol; 1989 Jan; 75(1):76-81. PubMed ID: 2467771
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Immunohistochemical study of the C5b-9 complex of complement in human kidneys.
    Hinglais N; Kazatchkine MD; Bhakdi S; Appay MD; Mandet C; Grossetete J; Bariety J
    Kidney Int; 1986 Sep; 30(3):399-410. PubMed ID: 3537447
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Immunohistochemical studies of vitronectin, C5b-9, and vitronectin receptor in membranous nephropathy.
    Ogawa T; Yorioka N; Yamakido M
    Nephron; 1994; 68(1):87-96. PubMed ID: 7527506
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Extensive deposits of complement C3d and C5b-9 in the choriocapillaris of eyes of patients with diabetic retinopathy.
    Gerl VB; Bohl J; Pitz S; Stoffelns B; Pfeiffer N; Bhakdi S
    Invest Ophthalmol Vis Sci; 2002 Apr; 43(4):1104-8. PubMed ID: 11923252
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Complement activation in amyloid plaques in Alzheimer's disease brains does not proceed further than C3.
    Veerhuis R; van der Valk P; Janssen I; Zhan SS; Van Nostrand WE; Eikelenboom P
    Virchows Arch; 1995; 426(6):603-10. PubMed ID: 7655742
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Vitronectin in children with renal disease--1. Immunofluorescence study of vitronectin and C5b-9 in childhood IgA nephropathy].
    Takahashi T; Inaba S; Okada T
    Nihon Jinzo Gakkai Shi; 1995 Apr; 37(4):213-23. PubMed ID: 7541480
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Activation of the human terminal complement pathway in atherosclerosis.
    Niculescu F; Rus HG; Vlaicu R
    Clin Immunol Immunopathol; 1987 Nov; 45(2):147-55. PubMed ID: 2444373
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Membranoproliferative glomerulonephritis. Localization of early components of complement in glomerular deposits.
    Davis BK; Cavallo T
    Am J Pathol; 1976 Aug; 84(2):283-98. PubMed ID: 133617
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Deposition of C3, the terminal complement complex and vitronectin in primary biliary cirrhosis and primary sclerosing cholangitis.
    Garred P; Lyon H; Christoffersen P; Mollnes TE; Tranum-Jensen J
    Liver; 1993 Dec; 13(6):305-10. PubMed ID: 7507546
    [TBL] [Abstract][Full Text] [Related]  

  • 11. SP-40,40, a newly identified normal human serum protein found in the SC5b-9 complex of complement and in the immune deposits in glomerulonephritis.
    Murphy BF; Kirszbaum L; Walker ID; d'Apice AJ
    J Clin Invest; 1988 Jun; 81(6):1858-64. PubMed ID: 2454950
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Immunohistochemical localization of the terminal C5b-9 complement complexes associated to S-protein and macrophage immunoreactive deposits in human damaged myocardial areas.
    Vlaicu R; Rus HG; Niculescu F
    Med Interne; 1988; 26(1):21-7. PubMed ID: 3399815
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Immunohistochemical localization of C5b-9, S-protein, C3d and apolipoprotein B in human arterial tissues with atherosclerosis.
    Niculescu F; Rus HG; Vlaicu R
    Atherosclerosis; 1987 May; 65(1-2):1-11. PubMed ID: 2955791
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The effect of aging on complement activity (CH50) and complement protein levels.
    Nagaki K; Hiramatsu S; Inai S; Sasaki A
    J Clin Lab Immunol; 1980 Jan; 3(1):45-50. PubMed ID: 7381926
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Activated complement in the sputum from patients with cystic fibrosis.
    Schiøtz PO; Sørensen H; Høiby M
    Acta Pathol Microbiol Scand C; 1979 Feb; 87C(1):1-5. PubMed ID: 433601
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Molecular basis of complement resistance of human melanoma cells expressing the C3-cleaving membrane protease p65.
    Ollert MW; Kadlec JV; Petrella EC; Bredehorst R; Vogel CW
    Cancer Res; 1993 Feb; 53(3):592-9. PubMed ID: 8425193
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Deposition of the terminal C5b-9 complement complex in infarcted areas of human myocardium.
    Schäfer H; Mathey D; Hugo F; Bhakdi S
    J Immunol; 1986 Sep; 137(6):1945-9. PubMed ID: 3528291
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Complement localization in ischemic baboon myocardium.
    McManus LM; Kolb WP; Crawford MH; O'Rourke RA; Grover FL; Pinckard RN
    Lab Invest; 1983 Apr; 48(4):436-47. PubMed ID: 6339810
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Activation mechanism and reaction process of the complement system--the classical pathway].
    Sakai K; Yasuda M; Tomooka K; Nobunaga M
    Nihon Rinsho; 1979 May; 37(5):943-55. PubMed ID: 381725
    [No Abstract]   [Full Text] [Related]  

  • 20. [Activation of complement during cardiopulmonary bypass--comparative study using 4 different oxygenators].
    Soejima K; Koyanagi H; Endo M; Hashimoto A; Imai Y
    Nihon Kyobu Geka Gakkai Zasshi; 1987 Feb; 35(2):200-4. PubMed ID: 3495614
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.